VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EDIT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EDITEditas Medicine, Inc.
$3.75$367M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEDITQuarterly Financials

Editas Medicine, Inc. (EDIT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Editas Medicine, Inc. (EDIT) quarterly income statement — complete revenue, gross profit & net income history

EDIT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue2.83M24.74M7.54M3.58M4.66M30.6M61K513K1.14M60.05M5.34M2.89M9.85M6.54M42K6.36M6.77M12.47M6.2M379K
Revenue Growth %-39.22%-19.16%12265.57%597.47%310.4%-49.04%-98.86%-82.23%-88.48%818.74%12604.76%-54.62%45.49%-47.58%-99.32%1578.63%4.19%9.2%-90.14%-96.47%
Cost of Goods Sold483K000001.6M1.42M1.41M1.47M1.51M29.78M37.8M52M41.33M43.66M37.98M37.55M29.27M33.75M
COGS % of Revenue17.06%-----2621.31%276.8%124.14%2.44%28.37%1031.49%383.76%795.56%98395.24%686.25%560.86%301.17%472.24%8905.8%
Gross Profit2.35M24.74M7.54M3.58M4.66M30.6M-1.54M-907K-274K58.58M3.82M-26.89M-27.95M-45.46M-41.28M-37.3M-31.2M-25.08M-23.07M-33.37M
Gross Margin %82.94%100%100%100%100%100%-2521.31%-176.8%-24.14%97.56%71.63%-931.49%-283.76%-695.56%-98295.24%-586.25%-460.86%-201.17%-372.24%-8805.8%
Gross Profit Growth %-49.59%-19.16%590.44%494.49%1800%-47.76%-140.24%96.63%99.02%228.86%109.26%27.9%10.42%-81.24%-78.97%-11.75%11.94%49.92%-179.75%-93.38%
Operating Expenses27.35M38.76M32.09M55.12M80.82M77.2M64.13M71M66.72M82.55M53.98M17.2M23.01M17.98M16.24M16.94M19.55M16.53M16.18M22.03M
OpEx % of Revenue966.13%156.65%425.44%1540.58%1735.1%252.24%105127.87%13839.38%5878.15%137.46%1011.71%595.84%233.56%275.15%38657.14%266.22%288.66%132.54%261.17%5811.87%
Selling, General & Admin10.23M11.35M12.32M12.86M13.38M16.35M18.09M18.21M19.34M14.46M14.99M17.2M23.01M17.98M16.24M16.94M19.55M16.53M16.18M22.03M
SG&A % of Revenue361.5%45.89%163.28%359.39%287.14%53.44%29652.46%3548.93%1703.88%24.07%280.87%595.84%233.56%275.15%38657.14%266.22%288.66%132.54%261.17%5811.87%
Research & Development2.83M27.4M19.77M16.18M26.59M48.61M47.64M52.79M47.38M68.09M5.34M29.78M37.8M52M41.33M43.66M37.98M37.55M29.27M33.75M
R&D % of Revenue100%110.76%262.16%452.24%570.91%158.84%78096.72%10290.45%4174.27%113.39%100%1031.49%383.76%795.56%98395.24%686.25%560.86%301.17%472.24%8905.8%
Other Operating Expenses1000K001000K1000K1000K-1000K0001000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-25M-14.02M-24.55M-51.54M-76.16M-46.59M-65.67M-71.9M-66.99M-23.96M-50.16M-44.09M-50.96M-63.45M-57.52M-54.23M-50.75M-41.61M-39.25M-55.4M
Operating Margin %-883.19%-56.65%-325.44%-1440.58%-1635.1%-152.24%-107649.18%-14016.18%-5902.29%-39.9%-940.09%-1527.33%-517.32%-970.72%-136952.38%-852.47%-749.52%-333.71%-633.42%-14617.68%
Operating Income Growth %67.17%69.92%62.62%28.31%-13.69%-94.45%-30.91%-63.07%-31.46%62.23%12.79%18.7%-0.42%-52.48%-46.54%2.11%10.78%36.83%-536.68%-76.78%
EBITDA-24.52M-13.21M-23.83M-49.71M-74.25M-45.21M-64.07M-70.48M-65.58M-22.5M-48.65M-42.55M-49.42M-61.87M-55.92M-52.64M-49.19M-40.1M-38.06M-54.21M
EBITDA Margin %-866.13%-53.4%-315.88%-1389.32%-1593.95%-147.73%-105027.87%-13739.38%-5778.15%-37.46%-911.71%-1473.99%-501.64%-946.59%-133133.33%-827.35%-726.51%-321.59%-614.22%-14303.96%
EBITDA Growth %66.97%70.78%62.81%29.47%-13.21%-100.98%-31.69%-65.63%-32.71%63.64%13%19.15%-0.46%-54.29%-46.9%2.91%11.72%38.01%-477.01%-77.93%
D&A (Non-Cash Add-back)483K805K721K1.83M1.92M1.38M1.6M1.42M1.41M1.47M1.51M1.54M1.54M1.58M1.6M1.6M1.56M1.51M1.19M1.19M
EBIT-25M-6.08M-22.72M-51.22M-73.87M-34.36M-62.14M-71.9M-66.99M-23.96M-50.16M-44.09M-50.96M-63.45M-57.52M-54.23M-50.75M-41.61M-39.25M-55.4M
Net Interest Income134K1K-568K67K500K1.2M3.53M4.3M5.04M5.1M5.14M3.81M3.51M1.42M1.79M546K469K1.91M152K146K
Interest Income1.21M-6.63M1.83M2.09M2.72M1.2M3.53M4.3M5.04M5.1M5.14M3.81M3.51M1.42M1.79M546K469K1.91M152K146K
Interest Expense1.07M-6.63M2.4M2.02M2.22M000000000000000
Other Income/Expense21K8.4M-569K-1.69M75K1.2M3.52M4.3M5.04M5.09M5.14M3.8M1.93M2.71M1.79M781K235K174K171K145K
Pretax Income-24.98M-5.62M-25.12M-53.23M-76.09M-45.4M-62.14M-67.61M-61.95M-18.87M-45.02M-40.29M-49.04M-60.74M-55.73M-53.45M-50.52M-41.44M-39.08M-55.26M
Pretax Margin %-882.44%-22.72%-332.98%-1487.84%-1633.49%-148.33%-101870.49%-13178.75%-5458.15%-31.43%-843.68%-1395.57%-497.78%-929.28%-132680.95%-840.19%-746.05%-332.31%-630.66%-14579.42%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-24.98M-5.62M-25.12M-53.23M-76.09M-45.4M-62.14M-67.61M-61.95M-18.87M-45.02M-40.29M-49.04M-60.74M-55.73M-53.45M-50.52M-41.44M-39.08M-55.26M
Net Margin %-882.44%-22.72%-332.98%-1487.84%-1633.49%-148.33%-101870.49%-13178.75%-5458.15%-31.43%-843.68%-1395.57%-497.78%-929.28%-132680.95%-840.19%-746.05%-332.31%-630.66%-14579.42%
Net Income Growth %67.17%87.62%59.58%21.26%-22.82%-140.52%-38.03%-67.8%-26.34%68.93%19.21%24.63%2.93%-46.58%-42.59%3.26%10.95%33.7%-599.83%-134.41%
Net Income (Continuing)-24.98M-5.62M-25.12M-53.23M-76.09M-45.4M-62.14M-67.61M-61.95M-18.87M-45.02M-40.29M-49.04M-60.74M-55.73M-53.45M-50.52M-41.44M-39.08M-55.26M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.26-0.06-0.28-0.63-0.92-0.55-0.75-0.82-0.76-0.23-0.55-0.56-0.66-0.80-0.78-0.77-0.73-0.61-0.57-0.81
EPS Growth %71.74%89.49%62.67%23.17%-21.05%-139.13%-36.36%-46.43%-15.15%71.25%29.49%27.27%9.59%-31.15%-36.84%4.94%15.12%39%-575%-88.37%
EPS (Basic)-0.26-0.06-0.28-0.63-0.92-0.55-0.75-0.82-0.76-0.23-0.55-0.56-0.66-0.80-0.78-0.77-0.74-0.61-0.57-0.81
Diluted Shares Outstanding97.88M88.75M90.09M84.41M83.06M82.61M82.49M82.31M81.94M81.71M81.65M71.38M68.92M68.79M68.74M68.64M68.48M68.36M68.22M67.88M
Basic Shares Outstanding97.88M88.75M90.09M84.41M83.06M82.61M82.49M82.31M81.94M81.71M81.65M71.38M68.92M68.79M68.74M68.64M68.26M68.36M68.22M67.88M
Dividend Payout Ratio--------------------